Evidence map›Paper›PMID 41111594›Full record

ArticleJournal of sickle cell disease2025

A patient-centered, theory-guided approach to examining the barriers and enablers to trial participation among people with SCD.

Kelly Carroll, Natasha Hudek, Justin Presseau, Lanre Tunji-Ajayi, Dawn P Richards, Susan Marlin, Jamie C Brehaut

Abstract read
In one paragraph

Article in Journal of sickle cell disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kelly CarrollMethodological and Implementation Research, Ottawa Hospital Research Institute (OHRI), The Ottawa Hospital, General Campus, Ottawa, ON K1H 8L6, Canada.ORCID https://orcid.org/0000-0002-7367-0270
Natasha HudekMethodological and Implementation Research, Ottawa Hospital Research Institute (OHRI), The Ottawa Hospital, General Campus, Ottawa, ON K1H 8L6, Canada.ORCID https://orcid.org/0000-0002-3486-7871
Justin PresseauMethodological and Implementation Research, Ottawa Hospital Research Institute (OHRI), The Ottawa Hospital, General Campus, Ottawa, ON K1H 8L6, Canada.ORCID https://orcid.org/0000-0002-2132-0703
Lanre Tunji-AjayiSickle Cell Awareness Group of Ontario (SCAGO), North York, ON M9L 2Y8, Canada.ORCID https://orcid.org/0009-0005-3375-1737
Dawn P RichardsClinical Trials Ontario, MaRS Centre, Toronto, ON M5G 1M1, Canada.ORCID https://orcid.org/0000-0003-1151-0826
Susan MarlinClinical Trials Ontario, MaRS Centre, Toronto, ON M5G 1M1, Canada.ORCID https://orcid.org/0000-0001-8971-7478
Jamie C BrehautMethodological and Implementation Research, Ottawa Hospital Research Institute (OHRI), The Ottawa Hospital, General Campus, Ottawa, ON K1H 8L6, Canada.ORCID https://orcid.org/0000-0002-4213-1143

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Recruitment to clinical trials involving sickle cell disease (SCD) patients can be challenging, leaving trialists uncertain about how to optimize recruitment approaches and strategies. Informed by the Theoretical Domains Framework (TDF), we identified a comprehensive set of barriers and enablers to participation in SCD trials, and suggest how this theory-informed survey approach can improve trial recruitment strategies. Methods: In collaboration with Clinical Trials Ontario and Sickle Cell Awareness Group of Ontario (SCAGO), we conducted a mixed methods study involving interviews with and surveys of SCD patients and families. We iteratively adapted a template survey based on think-aloud interviews, before administering the adapted survey online to SCAGO membership. Results: Fifteen interviews with SCAGO members led to 49 survey items across 13 of 14 TDF domains. Four new items specific to the SCD community were added. Administration challenges led to low survey response, with only 22 people completing the survey. Eighteen items from 8 domains were seen as barriers (eg invasive tests/procedures, travel to study site). Twenty-two items from 9 domains were seen as enablers (eg hope for a cure, helping others). Conclusion: Our theory-guided approach identified a comprehensive set of factors related to SCD trial participation, information that can support recruitment strategy development prior to trial onset. Low survey response rates precluded strong conclusions about the relative priority of the individual barriers and enablers; more work will be needed among a broader sample of SCD patients and families. Identification of theory-guided behavioral domains offers targeted suggestions for trial recruitment.

Indexed as

mixed methodsrecruitmentSCDtheoretical domains frameworktheorytrial participation

Identifiers

PMID41111594
PMCPMC12529103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.